目的探讨运动再学习(motor relearning program,MRP)[1]与强制性使用运动疗法(constraint-induced movement therapy,CIMT)[2]相结合对脑卒中偏瘫患者上、下肢运动功能的康复疗效。方法选择符合入选标准的60例脑卒中偏瘫患者。在基线期...目的探讨运动再学习(motor relearning program,MRP)[1]与强制性使用运动疗法(constraint-induced movement therapy,CIMT)[2]相结合对脑卒中偏瘫患者上、下肢运动功能的康复疗效。方法选择符合入选标准的60例脑卒中偏瘫患者。在基线期采用MRP促进偏瘫侧上、下肢恢复一定的主动运动,随后上肢采用改良的CIMT,在治疗期间健侧穿戴吊带和夹板限制肢体活动,每天清醒时固定时间不少于90%,同时接受塑性训练。下肢CIMT训练的内容主要包括:起坐训练,运动平板训练,上下楼梯训练,平衡训练,单腿负重等。在CIMT治疗的前8周的基线期、治疗前和治疗后分别采用简易上肢功能检查(STEF)和10m最大步行速度(MWS)来评价患者的上、下肢运动功能。结果60例患者全部进入结果分析。常规康复治疗前后比较:STEF和MWS功平均平均提高(3.0±1.2)分和(3.1±0.9)s,效应值分别为0.11和0.14。MRP与CIMT相结合治疗前后比较:STEF和MWS功平均提高(27.3±11.1)分和(10.1±6.7)s,效应值分别为1.73和0.51。结论MRP与CIMT相结合可以有效的改善脑卒中偏瘫患者上、下肢运动功能,提高日常生活活动能力,疗效明显优于常规治疗。展开更多
Objectives:This study aimed to assess the effects of modified pulmonary rehabilitation(PR)on patients with moderate to severe chronic obstructive pulmonary disease(COPD).Methods:A total of 125 patients(63 in the PR gr...Objectives:This study aimed to assess the effects of modified pulmonary rehabilitation(PR)on patients with moderate to severe chronic obstructive pulmonary disease(COPD).Methods:A total of 125 patients(63 in the PR group and 62 in the control group)were recruited in this study.The patients in the PR group received 12 weeks of conventional treatment,nursing,and modified pulmonary rehabilitation,while the patients in the control group underwent 12 weeks of conventional treatment,nursing,pursed-lip breathing training,and abdominal breathing training.Baseline characteristics,St.George's Respiratory Questionnaire(SGRQ),the six-minute walk test(6MWT),modified medical research council(MMRC)dyspnea scale,and lung function were compared between the two groups.Results:A total of 112 patients(58 patients in the PR group and 54 patients in the control group)completed the 12-week monitoring and follow-up.The SGRQ scores,symptoms(54.933±11.900),activity(52.644±14.334),impact(55.400±9.905),and total score(54.655±10.681)of the PR group did not significantly differ in pre-and post-treatments(P<0.05).No significant change was also observed in the control group(P>0.05).6MWT[(372.089±67.149)m]was significantly improved in the PR group(P<0.05)but was not significantly different in the control group(P>0.05).MMRC(actual rank sum 1719,rank sum 2047.5)was significantly reduced in the PR group(P<0.05)but not in the control group(P>0.05).The lung function(FVC,FEV1,FEV1/FVC,FEV1%and PEF)of the patients in both groups did not significantly change(P>0.05).Conclusion:Modified PR reduces the symptoms of dyspnea,increases exercise capacity,and improves the quality of life of patients with moderate to severe COPD.展开更多
文摘目的探讨运动再学习(motor relearning program,MRP)[1]与强制性使用运动疗法(constraint-induced movement therapy,CIMT)[2]相结合对脑卒中偏瘫患者上、下肢运动功能的康复疗效。方法选择符合入选标准的60例脑卒中偏瘫患者。在基线期采用MRP促进偏瘫侧上、下肢恢复一定的主动运动,随后上肢采用改良的CIMT,在治疗期间健侧穿戴吊带和夹板限制肢体活动,每天清醒时固定时间不少于90%,同时接受塑性训练。下肢CIMT训练的内容主要包括:起坐训练,运动平板训练,上下楼梯训练,平衡训练,单腿负重等。在CIMT治疗的前8周的基线期、治疗前和治疗后分别采用简易上肢功能检查(STEF)和10m最大步行速度(MWS)来评价患者的上、下肢运动功能。结果60例患者全部进入结果分析。常规康复治疗前后比较:STEF和MWS功平均平均提高(3.0±1.2)分和(3.1±0.9)s,效应值分别为0.11和0.14。MRP与CIMT相结合治疗前后比较:STEF和MWS功平均提高(27.3±11.1)分和(10.1±6.7)s,效应值分别为1.73和0.51。结论MRP与CIMT相结合可以有效的改善脑卒中偏瘫患者上、下肢运动功能,提高日常生活活动能力,疗效明显优于常规治疗。
基金This work was financially supported by the Instructive Research Program of Changzhou Municipal Commission of Health and Family Planning(WZ201417)
文摘Objectives:This study aimed to assess the effects of modified pulmonary rehabilitation(PR)on patients with moderate to severe chronic obstructive pulmonary disease(COPD).Methods:A total of 125 patients(63 in the PR group and 62 in the control group)were recruited in this study.The patients in the PR group received 12 weeks of conventional treatment,nursing,and modified pulmonary rehabilitation,while the patients in the control group underwent 12 weeks of conventional treatment,nursing,pursed-lip breathing training,and abdominal breathing training.Baseline characteristics,St.George's Respiratory Questionnaire(SGRQ),the six-minute walk test(6MWT),modified medical research council(MMRC)dyspnea scale,and lung function were compared between the two groups.Results:A total of 112 patients(58 patients in the PR group and 54 patients in the control group)completed the 12-week monitoring and follow-up.The SGRQ scores,symptoms(54.933±11.900),activity(52.644±14.334),impact(55.400±9.905),and total score(54.655±10.681)of the PR group did not significantly differ in pre-and post-treatments(P<0.05).No significant change was also observed in the control group(P>0.05).6MWT[(372.089±67.149)m]was significantly improved in the PR group(P<0.05)but was not significantly different in the control group(P>0.05).MMRC(actual rank sum 1719,rank sum 2047.5)was significantly reduced in the PR group(P<0.05)but not in the control group(P>0.05).The lung function(FVC,FEV1,FEV1/FVC,FEV1%and PEF)of the patients in both groups did not significantly change(P>0.05).Conclusion:Modified PR reduces the symptoms of dyspnea,increases exercise capacity,and improves the quality of life of patients with moderate to severe COPD.